auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Qu Biologics Inc.Department
National Research Council CanadaAmount
$2.8M
Province
BCType
Contribution
Agreement Number
172-2020-2021-Q3-961167
Purpose
This project will provide proof-of-concept evidence for the safety and efficacy for the prophylactic and therapeutic use of a lung-directed immunomodulator, to prevent serious COVID-19 infection.
Qu Biologics Inc. × National Research Council Canada
22 grants totalling $35.9M
Industrial Research Assistance Program – Contributions to Firms
26,784 grants totalling $5.1B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| ILLUMIN INC. | $10.0M | Industrial Research Assistance Program –... |